{
  "id": 3665468,
  "title": "Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates",
  "url": "https://urgent.news/2026/08/27/junshi-biosciences-announces-2026-interim-financial-results-and",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-27T04:01:42.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/junshi-biosciences-announces-2026-interim-financial-results-and-provides-corporate-updates"
  },
  "original_language": "en",
  "account": null,
  "summary": "SHANGHAI, Aug. 26, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2026 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS As of June 30, 2026, the company’s…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}